Home  |  Contact

Cellosaurus K562-Wnt5a (CVCL_XE50)

[Text version]
Cell line name K562-Wnt5a
Accession CVCL_XE50
Resource Identification Initiative To cite this cell line use: K562-Wnt5a (RRID:CVCL_XE50)
Comments Group: Patented cell line.
Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200958.
Population: Caucasian.
Transfected with: HGNC; 12784; WNT5A.
Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
Sequence variations
  • Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
  • Mutation; HGNC; 11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
Disease Blast phase chronic myelogenous leukemia, BCR-ABL1 positive (NCIt: C9110)
Chronic myeloid leukemia (ORDO: Orphanet_521)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0004 (K-562)
Sex of cell Female
Age at sampling 53Y
Category Cancer cell line
Publications

Patent=CN101724603A
Si W.-K., Li J., Li Z.-Q., Pan J., Niu C.-C., Zhao W.
Transgenic cell K562-Wnt5a and preparation method thereof.
Patent number CN101724603A, 09-Jun-2010

PubMed=21069266; DOI=10.3892/ijmm.2010.560
Yuan Y., Niu C.-C., Deng G., Li Z.-Q., Pan J., Zhao C., Yang Z.-L., Si W.-K.
The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
Int. J. Mol. Med. 27:63-69(2011)

Cross-references
Cell line databases/resources CCRID; 4201PAT-CCTCC00313
Encyclopedic resources Wikidata; Q94335728
Entry history
Entry creation06-Sep-2019
Last entry update29-Jun-2023
Version number10